{"id":"https://openalex.org/W7128095563","doi":null,"title":"[Botulinum toxin type A in the preventive treatment of chronic migraine: experience in a headache center in Argentina].","display_name":"[Botulinum toxin type A in the preventive treatment of chronic migraine: experience in a headache center in Argentina].","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7128095563","pmid":"https://pubmed.ncbi.nlm.nih.gov/41643086"},"language":"es","primary_location":{"id":"pmid:41643086","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41643086","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicina","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043536029","display_name":"Natalia Larripa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100158","display_name":"Fundaci\u00f3n para la Lucha contra las Enfermedades Neurol\u00f3gicas de la Infancia","ror":"https://ror.org/0145s0423","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210100158"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Natalia A Larripa","raw_affiliation_strings":["Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina. E-mail: natalialarripa@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina. E-mail: natalialarripa@gmail.com","institution_ids":["https://openalex.org/I4210100158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032706613","display_name":"Mariela Grandinetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100158","display_name":"Fundaci\u00f3n para la Lucha contra las Enfermedades Neurol\u00f3gicas de la Infancia","ror":"https://ror.org/0145s0423","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210100158"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Mariela Grandinetti","raw_affiliation_strings":["Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210100158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125228503","display_name":"Daniela Calvo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100158","display_name":"Fundaci\u00f3n para la Lucha contra las Enfermedades Neurol\u00f3gicas de la Infancia","ror":"https://ror.org/0145s0423","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210100158"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Daniela Calvo","raw_affiliation_strings":["Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210100158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029505600","display_name":"Vanesa Nagel","orcid":"https://orcid.org/0009-0001-2329-8263","observed_orcids":["https://orcid.org/0009-0001-2329-8263"]},"institutions":[{"id":"https://openalex.org/I4210100158","display_name":"Fundaci\u00f3n para la Lucha contra las Enfermedades Neurol\u00f3gicas de la Infancia","ror":"https://ror.org/0145s0423","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210100158"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Vanesa Nagel","raw_affiliation_strings":["Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210100158"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041429183","display_name":"Mar\u00eda Teresa Goicochea","orcid":"https://orcid.org/0000-0002-1491-7405","observed_orcids":["https://orcid.org/0000-0002-1491-7405"]},"institutions":[{"id":"https://openalex.org/I4210100158","display_name":"Fundaci\u00f3n para la Lucha contra las Enfermedades Neurol\u00f3gicas de la Infancia","ror":"https://ror.org/0145s0423","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210100158"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"M Teresa Goicochea","raw_affiliation_strings":["Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica de Cefalea, Departamento de Neurolog\u00eda, FLENI, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210100158"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210100158"],"apc_list":null,"apc_paid":null,"fwci":3.0444,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.84363713,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"86","issue":"1","first_page":"139","last_page":"144"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10852","display_name":"Temporomandibular Joint Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3504","display_name":"Oral Surgery"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-migraine","display_name":"chronic migraine","score":0.8569999933242798},{"id":"https://openalex.org/keywords/onabotulinumtoxina","display_name":"onabotulinumtoxinA","score":0.9369999766349792},{"id":"https://openalex.org/keywords/botulinum-toxin-type-a","display_name":"botulinum toxin type A","score":0.9900000095367432},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.781000018119812},{"id":"https://openalex.org/keywords/medication-overuse-headache","display_name":"medication overuse headache","score":0.8960000276565552},{"id":"https://openalex.org/keywords/headache-frequency-reduction","display_name":"headache frequency reduction","score":0.7260000109672546},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9229999780654907},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.5720000267028809},{"id":"https://openalex.org/keywords/argentina","display_name":"Argentina","score":0.8450000286102295}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8544999957084656},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3896999955177307},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3862999975681305},{"id":"https://openalex.org/C2779463800","wikidata":"https://www.wikidata.org/wiki/Q5062222","display_name":"Center (category theory)","level":2,"score":0.37139999866485596},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.350600004196167},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33379998803138733},{"id":"https://openalex.org/C2910587157","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Chronic Migraine","level":3,"score":0.3321000039577484},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29490000009536743},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.28780001401901245},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2752000093460083},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.26429998874664307}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001118","descriptor_name":"Argentina","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D009465","descriptor_name":"Neuromuscular Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:41643086","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41643086","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicina","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W61198599","https://openalex.org/W2885688602","https://openalex.org/W2169940515","https://openalex.org/W4240416262","https://openalex.org/W2175258110","https://openalex.org/W4385298952","https://openalex.org/W2143744763","https://openalex.org/W2564898880","https://openalex.org/W168393487","https://openalex.org/W2556396441"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Chronic":[1],"migraine":[2],"(CM)":[3],"is":[4,29],"one":[5],"of":[6,18,23,37,55,77,81,111],"the":[7,21,35,52,146,196],"most":[8],"disabling":[9],"neurological":[10],"diseases,":[11],"with":[12,57,60,85,188],"a":[13,63,74],"marked":[14],"impact":[15],"on":[16,34],"quality":[17],"life":[19],"and":[20,89,105,161,172,178,191,194],"use":[22,36],"health":[24],"resources.":[25],"In":[26],"Argentina,":[27],"there":[28],"no":[30],"published":[31,198],"real-life":[32],"data":[33],"botulinum":[38],"toxin":[39],"type":[40],"A;":[41],"onabotulinumtoxinA":[42],"(onabotA),":[43],"in":[44,67,126,157,174,181,200],"chronic":[45],"migraine.":[46],"The":[47],"objective":[48],"was":[49,124,168],"to":[50],"describe":[51],"clinical":[53],"outcomes":[54],"patients":[56,83,113,148],"CM":[58,182],"treated":[59,84],"onabotA":[61,86],"at":[62],"specialized":[64],"headache":[65,101,151,159,176],"center":[66],"Argentina.":[68,201],"MATERIALS":[69],"AND":[70],"METHODS:":[71],"We":[72],"conducted":[73],"retrospective":[75],"review":[76],"electronic":[78],"medical":[79],"records":[80],"all":[82],"between":[87],"January":[88],"December":[90],"2021.":[91],"Data":[92],"collected":[93],"included":[94],"demographics,":[95],"medication":[96,164,179],"overuse,":[97],"prior":[98],"preventive":[99],"therapies,":[100],"diaries,":[102,152],"treatment":[103],"response,":[104],"adverse":[106],"events.":[107],"RESULTS:":[108],"A":[109],"total":[110],"394":[112],"were":[114,137],"analyzed":[115],"(91%":[116],"women;":[117],"mean":[118],"age":[119],"46":[120],"years).":[121],"Medication":[122],"overuse":[123,180],"present":[125],"66%":[127],"(n=241).":[128],"Forty":[129],"percent":[130],"(n=160)":[131],"reported":[132,138],"end-of-dose":[133],"deterioration.":[134],"Adverse":[135],"events":[136],"by":[139],"4%":[140],"(n=15),":[141],"none":[142],"requiring":[143],"discontinuation.":[144],"Among":[145],"162":[147],"who":[149],"completed":[150],"65%":[153],"achieved":[154],"\u226550%":[155],"reduction":[156],"monthly":[158],"days,":[160],"34%":[162],"reversed":[163],"overuse.":[165],"CONCLUSION:":[166],"OnabotA":[167],"safe,":[169],"well":[170],"tolerated,":[171],"effective":[173],"reducing":[175],"frequency":[177],"patients.":[183],"Our":[184],"findings":[185],"are":[186],"consistent":[187],"pivotal":[189],"trials":[190],"real-world":[192],"studies":[193],"represent":[195],"first":[197],"experience":[199]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-02-07T00:00:00"}